Insider Trading29 Jun 2026, 10:00 am
Parmax Pharma Closes Trading Window for Q1 FY27 Results
AI Summary
Parmax Pharma Ltd has announced the closure of its trading window for designated persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 01, 2026, until 48 hours after the declaration of financial results for the quarter ending June 30, 2026. The specific date of the board meeting to consider these results will be communicated later.
Key Highlights
- Trading window closed for designated persons from July 1, 2026.
- Closure is for Q1 FY27 financial results announcement.
- Effective until 48 hours post-results declaration.
- Compliance with SEBI Insider Trading Regulations.
- Board meeting date for results to be announced separately.
Price Impact
More from PARMAX